AVIR
Price
$3.46
Change
+$0.06 (+1.76%)
Updated
Sep 3 closing price
Capitalization
275.37M
63 days until earnings call
VNDA
Price
$4.72
Change
+$0.01 (+0.21%)
Updated
Sep 3 closing price
Capitalization
279.2M
55 days until earnings call
Interact to see
Advertisement

AVIR vs VNDA

Header iconAVIR vs VNDA Comparison
Open Charts AVIR vs VNDABanner chart's image
Atea Pharmaceuticals
Price$3.46
Change+$0.06 (+1.76%)
Volume$159.48K
Capitalization275.37M
Vanda Pharmaceuticals
Price$4.72
Change+$0.01 (+0.21%)
Volume$342.67K
Capitalization279.2M
AVIR vs VNDA Comparison Chart in %
Loading...
AVIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VNDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVIR vs. VNDA commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVIR is a Hold and VNDA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (AVIR: $3.46 vs. VNDA: $4.71)
Brand notoriety: AVIR and VNDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVIR: 44% vs. VNDA: 140%
Market capitalization -- AVIR: $275.37M vs. VNDA: $279.2M
AVIR [@Biotechnology] is valued at $275.37M. VNDA’s [@Biotechnology] market capitalization is $279.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVIR’s FA Score shows that 0 FA rating(s) are green whileVNDA’s FA Score has 1 green FA rating(s).

  • AVIR’s FA Score: 0 green, 5 red.
  • VNDA’s FA Score: 1 green, 4 red.
According to our system of comparison, both AVIR and VNDA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVIR’s TA Score shows that 4 TA indicator(s) are bullish while VNDA’s TA Score has 7 bullish TA indicator(s).

  • AVIR’s TA Score: 4 bullish, 5 bearish.
  • VNDA’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, VNDA is a better buy in the short-term than AVIR.

Price Growth

AVIR (@Biotechnology) experienced а -3.89% price change this week, while VNDA (@Biotechnology) price change was +0.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.29%. For the same industry, the average monthly price growth was +15.06%, and the average quarterly price growth was +30.89%.

Reported Earning Dates

AVIR is expected to report earnings on Nov 06, 2025.

VNDA is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+0.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VNDA($279M) and AVIR($275M) have the same market capitalization . AVIR YTD gains are higher at: 3.284 vs. VNDA (-1.670). VNDA has higher annual earnings (EBITDA): -92.87M vs. AVIR (-156.2M). AVIR has more cash in the bank: 380M vs. VNDA (326M). AVIR has less debt than VNDA: AVIR (1.25M) vs VNDA (11.6M). VNDA has higher revenues than AVIR: VNDA (203M) vs AVIR (0).
AVIRVNDAAVIR / VNDA
Capitalization275M279M99%
EBITDA-156.2M-92.87M168%
Gain YTD3.284-1.670-197%
P/E RatioN/A137.00-
Revenue0203M-
Total Cash380M326M117%
Total Debt1.25M11.6M11%
FUNDAMENTALS RATINGS
AVIR vs VNDA: Fundamental Ratings
AVIR
VNDA
OUTLOOK RATING
1..100
6211
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
83
Overvalued
PROFIT vs RISK RATING
1..100
95100
SMR RATING
1..100
9795
PRICE GROWTH RATING
1..100
5856
P/E GROWTH RATING
1..100
953
SEASONALITY SCORE
1..100
885

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AVIR's Valuation (36) in the Biotechnology industry is somewhat better than the same rating for VNDA (83). This means that AVIR’s stock grew somewhat faster than VNDA’s over the last 12 months.

AVIR's Profit vs Risk Rating (95) in the Biotechnology industry is in the same range as VNDA (100). This means that AVIR’s stock grew similarly to VNDA’s over the last 12 months.

VNDA's SMR Rating (95) in the Biotechnology industry is in the same range as AVIR (97). This means that VNDA’s stock grew similarly to AVIR’s over the last 12 months.

VNDA's Price Growth Rating (56) in the Biotechnology industry is in the same range as AVIR (58). This means that VNDA’s stock grew similarly to AVIR’s over the last 12 months.

VNDA's P/E Growth Rating (3) in the Biotechnology industry is significantly better than the same rating for AVIR (95). This means that VNDA’s stock grew significantly faster than AVIR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVIRVNDA
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
72%
Momentum
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
70%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 13 days ago
79%
Bullish Trend 6 days ago
70%
Declines
ODDS (%)
Bearish Trend 6 days ago
79%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
AVIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VNDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNPRF1.330.14
+11.50%
Condor Energies Inc.
PINXY12.48N/A
N/A
Peoples Insurance Company Group China
RGLXY3.84N/A
N/A
RTL Group SA
TCLAF14.80N/A
N/A
Transcontinental Inc.
ZOONF0.01N/A
N/A
ZOONO GROUP LTD.

VNDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VNDA has been loosely correlated with OCUL. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if VNDA jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VNDA
1D Price
Change %
VNDA100%
-0.42%
OCUL - VNDA
40%
Loosely correlated
+4.01%
IDYA - VNDA
38%
Loosely correlated
+3.79%
CGEM - VNDA
38%
Loosely correlated
-0.66%
AVIR - VNDA
38%
Loosely correlated
+1.19%
ZYME - VNDA
38%
Loosely correlated
-5.40%
More